AI assistant
Sending…
PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2020
Mar 23, 2020
33488_dirs_2020-03-23_ca7b331b-be2c-444b-8889-c8bc8b8abb02.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2020-03-16
Reporting Person: Ludwig Jeffrey Jerome (Chief Commercial Officer)
More from PUMA BIOTECHNOLOGY, INC.
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Feb 26
Earnings Release
2026
Feb 26
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Feb 21
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 8